Risk factors for recurrence in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer in Japan: a systematic literature review and meta-analysis
CONCLUSIONS: Identified risk factors were consistent with the previous reports, and this study provides quantitative summary of risk factors for HR+/HER2- early breast cancer recurrence in Japan. (PROSPERO Registration ID, CRD42022338391.).PMID:38597173 | DOI:10.1080/03007995.2024.2332436
Source: Current Medical Research and Opinion - Category: Research Authors: Naoki Miyazaki Toshiki Iwasaki Hitomi Sakai Rurina Watanuki Yoshinori Tanizawa Zhihong Cai Tsutomu Kawaguchi Junji Tsurutani Kengo Nagashima Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Databases & Libraries | HER2 | Hormones | Japan Health | Research | Study